New treatment strategy for patients with EGFR-mutant lung cancer

Author： Ninomiya Takashi   Takigawa Nagio   Toyooka Shinichi   Hotta Katsuyuki   Tanimoto Mitsune   Kiura Katsuyuki  

Publisher： Future Medicine

ISSN： 1758-1966

Source： Lung Cancer Management, Vol.2, Iss.6, 2013-12, pp. : 505-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Predictors of outcome for EGFR-mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors

By Pilotto Sara   Bria Emilio  

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 89-92

Future Medicine

Access to resources Recommend Favorite

Polymorphisms in intron 1 of the EGFR gene in nonsmall cell lung cancer patients

By                              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 785-789

Spandidos Publications

Access to resources Recommend Favorite

Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients

By              

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 271-276

Spandidos Publications

Access to resources Recommend Favorite

Determination of EGFR and KRAS mutational status in Greek nonsmallcell lung cancer patients

By                                          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2176-2184

Spandidos Publications

Access to resources Recommend Favorite

Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFRT790M mutant lung cancer

By          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2063-2066

Spandidos Publications

Access to resources Recommend Favorite